INFLAMATORY BOWEL DISEASE
Clinical trials for INFLAMATORY BOWEL DISEASE explained in plain language.
Never miss a new study
Get alerted when new INFLAMATORY BOWEL DISEASE trials appear
Sign up with your email to follow new studies for INFLAMATORY BOWEL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for patients with stubborn IBD
Disease control Recruiting nowThis study tests whether combining two drugs—guselkumab and a JAK inhibitor (like upadacitinib or tofacitinib)—can help people with inflammatory bowel disease (IBD) that hasn't responded to standard treatments. About 80 participants aged 14-80 with moderate to severe IBD will rec…
Matched conditions: INFLAMATORY BOWEL DISEASE
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
Hope for Crohn's patients: new drug trial for those who Didn't respond to previous therapy
Disease control Recruiting nowThis study looks at whether guselkumab can help people with moderate to severe Crohn's disease who did not get better with or could not tolerate another drug called ustekinumab. About 60 adults will receive guselkumab and be followed for 52 weeks to see if their symptoms improve …
Matched conditions: INFLAMATORY BOWEL DISEASE
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
Could a new PET scan catch Crohn's scarring before It's too late?
Diagnosis Recruiting nowThis study tests a special PET scan that uses a radioactive tracer to find early scarring in the small bowel of people with Crohn's disease. About 45 adults with Crohn's will get the scan to see if it can spot fibrosis before it causes blockages. The goal is to improve diagnosis …
Matched conditions: INFLAMATORY BOWEL DISEASE
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 15, 2026 11:57 UTC
-
New model aims to predict IBD drug success, saving time and money
Knowledge-focused Recruiting nowInflammatory bowel disease (IBD) is a lifelong condition with no cure. Biologic drugs are a common treatment, but they don't work for 30-50% of patients and are very expensive. This study will collect data from 200 IBD patients to build a model that predicts who will benefit from…
Matched conditions: INFLAMATORY BOWEL DISEASE
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:43 UTC